U.S. Drug Discovery Outsourcing Market Size & Outlook
U.S. drug discovery outsourcing market, 2018-2030 (US$M)
Related Markets
U.S. drug discovery outsourcing market highlights
- The U.S. drug discovery outsourcing market generated a revenue of USD 1,004.6 million in 2022 and is expected to reach USD 1,668.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2023 to 2030.
- In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2022.
- Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Drug discovery outsourcing market data book summary
| Market revenue in 2022 | USD 1,004.6 million |
| Market revenue in 2030 | USD 1,668.3 million |
| Growth rate | 6.5% (CAGR from 2022 to 2030) |
| Largest segment | Lead identification & candidate optimization |
| Fastest growing segment | Other Associated Workflow |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
| Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
Other key industry trends
- In terms of revenue, U.S. accounted for 28.3% of the global drug discovery outsourcing market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 447.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Outsourcing Market Scope
Drug Discovery Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. drug discovery outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 32.88% in 2022. Horizon Databook has segmented the U.S. drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.
U.S. is amongst the key markets in the international pharmaceutical industry and is responsible for around 80% of global pharmaceutical sales. Major factors such as developed infrastructure, increase in R&D investment, and rise in incidence of various diseases are driving the growth of drug discovery outsourcing market in the U.S.
In addition, public-private partnerships formed with the aim of developing novel drug molecules are expected to dramatically impact market growth in this region. For instance, Pfizer, Inc, has created many Centers for Therapeutic Innovations (CTI) in the U.S.
This company joined hands with 21 academic medical centers in the U.S. If the challenges faced in coordination are handled properly, strategic alliances can improve the competitive advantage of pharmaceutical enterprises and enhance public welfare by discovering and developing new drugs.
Reasons to subscribe to U.S. drug discovery outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. drug discovery outsourcing market databook
-
Our clientele includes a mix of drug discovery outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. drug discovery outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. drug discovery outsourcing market outlook size, by workflow, 2018-2030 (US$M)
U.S. Drug Discovery Outsourcing Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
